Echo Therapeutics (NSDQ:ECTE) said today that its future may be in jeopardy after getting hit with a restrictive injunction related to a whistleblower case alleging securities violations, theft of trade secrets and more. The company said it is facing a case in the U.S. District Court for Southern New York related to “various violations of the […]
Medical Technologies Innovation Asia
Diabetes: Echo Therapeutics gains after inking China deal
Echo Therapeutics (NSDQ:ECTE) said it inked a deal to license its Symphony continuous glucose monitor for the Chinese market, sending share prices up this week.